ARGOS THERAPEUTICS INC (ARGS) has 34 open-market insider trades by 13 insiders since 2014. The most active filer is Joint Stock Co Pharmstandard Public, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Joint Stock Co Pharmstandard Public | 10% Owner | — | 8 | $12.3M | 2017-06-21 |
| Pharmstandard International S.A. | 10% Owner | — | 8 | $2.0M | 2017-10-31 |
| Brian J. Underdown | Dir10% | — | 1 | $324K | 2014-02-12 |
| Hubert Birner | Dir | — | 1 | $319K | 2016-12-31 |
| Co-Investment Ii Cooperatief U.a. Forbion | 10% | — | 1 | $291K | 2014-02-12 |
| Sander van Deventer | Dir10% | — | 1 | $291K | 2016-09-30 |
| Philippe Marie Marcel Joseph van Holle | Dir | — | 5 | $234K | 2016-09-30 |
| Jeffrey D. Abbey | CEO | — | 4 | $47K | 2018-04-25 |
| Charles A. Nicolette | PresVP | — | 1 | $32K | 2018-04-25 |
| Jean Lamarre | Dir | — | 1 | $15K | 2015-08-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jeffrey D. Abbey | CEO & President | Sell | $20K | 2018-01-10 |
| Richard D. Katz | President & VP | Sell | $17K | 2018-01-10 |
| Lori R. Harrelson | President & VP | Sell | $10K | 2018-01-10 |
| Charles A. Nicolette | President & VP | Sell | $16K | 2018-01-10 |
| Richard D. Katz | President & VP | Sell | $17K | 2018-01-09 |
| Jeffrey D. Abbey | CEO & President | Sell | $20K |
Companies that share insiders with ARGS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-01-09 |
| Charles A. Nicolette | President & VP | Sell | $16K | 2018-01-09 |
| Lori R. Harrelson | President & VP | Sell | $10K | 2018-01-09 |
| Lori R. Harrelson | President & VP | Sell | $9K | 2018-01-03 |
| Richard D. Katz | President & VP | Sell | $16K | 2018-01-03 |
| Charles A. Nicolette | President & VP | Sell | $15K | 2018-01-03 |
| Jeffrey D. Abbey | CEO & President | Sell | $18K | 2018-01-03 |
| Joint Stock Co Pharmstandard Public | 10% Owner | Buy | $99K | 2016-10-07 |
| Pharmstandard International S.A. | 10% | Buy | $150K | 2016-10-04 |
| Joint Stock Co Pharmstandard Public | 10% Owner | Buy | $391K | 2016-09-30 |